|
CA3102509A1
|
|
Oral mucosal delivery systems comprising monophasic concentrate of teriparatide
|
|
EP3796899A1
|
|
Novel pharmaceutical composition of tamsulosin and dutasteride
|
|
WO2019198109A1
|
|
Novel pharmaceutical composition of essential oil
|
|
CA3096919A1
|
|
Composition of active ingredient loaded edible ink and methods of making suitable substrates for active ingredient printing on orodispersible films
|
|
WO2019008605A1
|
|
Novel pharmaceutical co-crystal of dabigatran etexilate
|
|
WO2018122867A1
|
|
Thin film formulations of 4-diphenylmethyl-1-piperazine derivatives and their salts
|
|
EP3691610A1
|
|
Process for the preparation of bi/multi-layer film, multi-layered film produced thereof and apparatus for producing such multi-layer films
|
|
EP3328364A1
|
|
Novel dual delayed release oral composition of dexlansoprazole
|
|
US2018185270A1
|
|
Mucosal delivery of vitamin b12
|
|
BR112017021995A2
|
|
pharmaceutical formulation comprising low fusion and highly lipophilic drugs and dissolution enhancing method
|
|
EP3082767A2
|
|
Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them
|
